|
|
|
 |
| |
| Carcinogenesis,
Teratogenesis & Mutagenesis
The forth Editorial Board
|
|
Huang
Tianhua |
|
|
|
Professor
of Biology and Genetics，Director of Research
Center for Reproductive Medicine, Director of
Cell Biology and Genetics of Shantou University
Medical College. The Specialist enjoying special
allowance from Government approved by State
Council of China since 1992.
He graduated from Biology Faculty of Sichuan
University in 1967 and from the Postgraduate
Class of Harbin Medical University in 1982.
Then he, as a visiting scholar, went to Asahikawa
Medical College of Japan, Medical School of
Hawaii University and Medical College of Cornell
University of USA to do research on Reproductive
Genetics and Medicine.
He is a Fellow, International Environmental
Mutagen Society, Deputy General Secretary of
Chinese Environmental Mutagen Society, Vice
President of Guangdong Provincial Environmental
Mutagen Society, Vice Chairman of the Committee
of Ethnic & Law of Chinese Genetics Society,
Member of Standing Committee of Guangdong Provincial
Genetics Society, Member of Council of the 6th
Committee of Science and Technology Association
of Shantou City and President of Shantou municipal
Genetics Society. He is also the Deputy Editor-in-Chief
(Executor) of Editorial Board for the journal
of Carcinogenesis, Teratogenesis and Mutagenesis,
the Executive Member of Editorial Board for
Chinese Journal of Practical Medicine,
the Member of Editorial Board for National
Journal of Andrology as well as for the
journal of Genetics Section of Foreign Medical
Sciences.
He bore responsibility for 16 National and
Provincial projects, and published 106 research
articles, and received 4 academic awards issued
by Ministry of Health, Ministry of Chemical
Industry, and State Family Planning Commission
of China and Sichuan Provincial Government.
For his achievement in scientific research,
he gained the title of National Excellent
Research Worker in 1989 and the title of
National Excellent Teacher in 1995, and
was awarded the Medal “May 1” of Guangdong
Province in 1997. In 2000 he gained the title
of Excellent Worker issued by Shantou
Municipal Government.
|
|
| |
|
|
|
| |
 |
| |
 |
| Cheng
Shujun is currently as a professor of Cancer
Institute (Hospital), Chinese Academy of Medical Sciences
& Peking Union Medical College, Beijing, China,
and Chief Scientist of both China State Key Basic
Research Project “Fundamental investigation of human
carcinogenesis and cancer therapy and prevention”
and Beijing key Cancer Research Project “Tumor biomarker
profiling and human cancer diagnosis and therapy”.
He worked as a visiting scientist in Laboratoire de
Medicine Experimental, Institute de la Recherches
Scientifiques sur le Cancer, France (1978-1981), and
in Department of Pathology, Medical College of Ohio,
USA (1986-1987). He has established a series of short-term
tests for the detection of environmental carcinogens
and anti-carcinogens in China. He was elected as a
Member, Chinese Academy of Engineering in 1999. Dr.
Cheng is the President of Chinese Environmental Mutagen
Society, and Vice President of China Anticancer Association.
He found that the tea catechins showed a significant
inhibitory effect against human genital condylomas
and inflammatory hyperplasia. Based on the invention,
he and his collaborators had received international
patents “Composition for treating condyloma acuminate”
in 1998. This invention had been approved to go for
clinical phase III trial by US FDA. As invited speakers,
Dr. Cheng has visited many institutes at foreign countries
and attended at international conferences. |
|
| |
|
